Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply

Robert H Jones*, Angela Casbard, Margherita Carucci, Andrew Foxley, Sacha J Howell

*Corresponding author for this work

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)e234
Number of pages1
JournalThe Lancet. Oncology
Volume21
Issue number5
DOIs
Publication statusPublished - May 2020

Keywords

  • aromatase
  • aromatase inhibitors
  • estrogens
  • fulvestrant
  • neoplasm recurrence, local

Cite this